ES548174A0 - Procedimiento de depuracion de antigeno del tipo de la hepa-titis - Google Patents

Procedimiento de depuracion de antigeno del tipo de la hepa-titis

Info

Publication number
ES548174A0
ES548174A0 ES548174A ES548174A ES548174A0 ES 548174 A0 ES548174 A0 ES 548174A0 ES 548174 A ES548174 A ES 548174A ES 548174 A ES548174 A ES 548174A ES 548174 A0 ES548174 A0 ES 548174A0
Authority
ES
Spain
Prior art keywords
depuration
hepa
procedure
type antigen
titis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES548174A
Other languages
English (en)
Other versions
ES8605295A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GC Biopharma Corp
Original Assignee
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Korea filed Critical Green Cross Corp Korea
Publication of ES548174A0 publication Critical patent/ES548174A0/es
Publication of ES8605295A1 publication Critical patent/ES8605295A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES548174A 1984-10-26 1985-10-24 Procedimiento de depuracion de antigeno del tipo de la hepa-titis Expired ES8605295A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59224116A JPS61103895A (ja) 1984-10-26 1984-10-26 ＨＢｓＡｇの精製方法

Publications (2)

Publication Number Publication Date
ES548174A0 true ES548174A0 (es) 1986-04-01
ES8605295A1 ES8605295A1 (es) 1986-04-01

Family

ID=16808783

Family Applications (1)

Application Number Title Priority Date Filing Date
ES548174A Expired ES8605295A1 (es) 1984-10-26 1985-10-24 Procedimiento de depuracion de antigeno del tipo de la hepa-titis

Country Status (7)

Country Link
US (1) US4694074A (es)
EP (1) EP0179485B1 (es)
JP (1) JPS61103895A (es)
KR (1) KR890001069B1 (es)
CA (1) CA1256042A (es)
DE (1) DE3579100D1 (es)
ES (1) ES8605295A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8402861L (sv) * 1984-05-28 1985-11-29 Stefan Svenson Rening av biologiskt material
US4883865A (en) * 1987-09-30 1989-11-28 Merck & Co. Inc. Recovery of pres2+s antigen
US5462863A (en) * 1989-02-09 1995-10-31 Development Center For Biotechnology Isolation of Hepatitis B surface antigen from transformed yeast cells
JP5999899B2 (ja) * 2008-04-08 2016-09-28 バイオ−ラッド ラボラトリーズ インコーポレーティッド 抗体のクロマトグラフィー精製法
AU2012335277B2 (en) 2011-11-11 2018-06-14 Variation Biotechnologies Inc. Compositions and methods for treatment of cytomegalovirus

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB883549A (en) * 1958-09-03 1961-11-29 Crookes Lab Ltd Improvements in and relating to the purification of antihaemophilic globulin
US3951937A (en) * 1973-12-20 1976-04-20 The Community Blood Council Of Greater New York, Inc. Large scale purification of hepatitis type B antigen using polyethylene glycol
US3976767A (en) * 1975-04-14 1976-08-24 The New York Blood Center Purification of hepatitis B surface antigen by chromatography on agarose containing aminoalkyl residues
IL49752A (en) * 1975-07-09 1979-07-25 Kabi Ab Compositions having affinity for hepatitis virus and method for hepatitis virus removal or concentration
DE2602892A1 (de) * 1976-01-27 1977-07-28 Community Blood Council Konzentriertes hepatitis-b-oberflaechenantigen enthaltende masse und verfahren zu ihrer herstellung
US4113712A (en) * 1976-03-08 1978-09-12 The Green Cross Corporation HBsAG Particle composed of single polypeptide subunits and the preparation procedure
SE420977B (sv) * 1976-03-18 1981-11-16 Kabi Ab Forfarande for rening och isolering av hepatitvirus for vaccinframstellning
US4162192A (en) * 1978-09-28 1979-07-24 Juridical Foundation Method for purification of HBs antigen
IE52036B1 (en) * 1979-05-24 1987-05-27 Univ California Non-passageable viruses
JPS5790650A (en) * 1980-11-28 1982-06-05 Toshiba Corp Control device for copying machine
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
US4434093A (en) * 1982-07-26 1984-02-28 Ortho Diagnostic Systems Inc. Methods for preparation of HBs Ag free gamma globulins
GB2125047B (en) * 1982-08-09 1986-02-19 Ciba Geigy Ag Yeast hybrid vectors and their use for the production of polypeptides
US4515714A (en) * 1983-03-09 1985-05-07 Juridicial Foundation, The Chemo-Semo-Sero-Therapeutic Research Institute Method for purification of hepatitis B virus surface antigen
EP0135435A3 (en) * 1983-08-22 1987-03-25 Merck & Co. Inc. Immunogenic hbsag derived from transformed yeast
JPS6078999A (ja) * 1983-10-05 1985-05-04 Chemo Sero Therapeut Res Inst ＨＢｓ抗原の精製方法
US4547368A (en) * 1983-12-20 1985-10-15 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Hepatitis B core antigen vaccine made by recombinant DNA
US4599230A (en) * 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants

Also Published As

Publication number Publication date
CA1256042A (en) 1989-06-20
EP0179485B1 (en) 1990-08-08
EP0179485A2 (en) 1986-04-30
KR860003337A (ko) 1986-05-23
JPS61103895A (ja) 1986-05-22
KR890001069B1 (ko) 1989-04-22
EP0179485A3 (en) 1988-09-28
ES8605295A1 (es) 1986-04-01
DE3579100D1 (de) 1990-09-13
JPH0548240B2 (es) 1993-07-20
US4694074A (en) 1987-09-15

Similar Documents

Publication Publication Date Title
IT8348322A0 (it) Sedia articolata
DK311782A (da) Tandboerste
DK604086A (da) Haarboerste
BR8305952A (pt) Preparacao de cosmetico
DK324387A (da) Aza-bicycliske forbindelser
DK237283D0 (da) Fungicidt praeparat
FI853249A0 (fi) Cdna-kloner foer human erytropoietin.
AR231073A1 (es) Preparacion dentifrica
DK449883D0 (da) Kosmetisk praeparat
DK324584D0 (da) Kosmetisk praeparat
PT85197A (pt) Escova de dentes
ES548174A0 (es) Procedimiento de depuracion de antigeno del tipo de la hepa-titis
DK406888A (da) Stige
FI834542A0 (fi) Diagnostiskt testmedel
DK393183D0 (da) Kosmetisk praeparat
NO830823L (no) Tannpleiemiddel
BR8304337A (pt) Mecanismo de sofa - cama
DK164130C (da) Symmetrisk doerlaas
IT8263354U1 (it) Doppia lattina
ATA119287A (de) Zahncreme
BR8704713A (pt) Espessador
LT2589B (lt) Zmogaus alpha -interferono isvalymo budas
KR840001877U (ko) 유아용 치솔
ATA126986A (de) Haarbuerste
BR8304136A (pt) Preparacao 2-t-butil-5-cloropirimidina

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010301